BMY - Bristol-Myers Squibb Company - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BMY is currently covered by 15 analysts with an average price target of $64.82. This is a potential upside of $12.02 (22.77%) from yesterday's end of day stock price of $52.8.

Bristol-Myers Squibb Company's activity chart (see below) currently has 167 price targets and 166 ratings on display. The stock rating distribution of BMY is 54.9% HOLD, 15.69% SELL and 29.41% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72.09% with an average time for these price targets to be met of 663.21 days.

Highest price target for BMY is $69, Lowest price target is $42, average price target is $64.82.

Most recent stock forecast was given by EVAN SEIGERMAN from BMO on 27-Sep-2024. First documented stock forecast 22-May-2013.

Currently out of the existing stock ratings of BMY, 28 are a HOLD (54.9%), 8 are a SELL (15.69%), 15 are a BUY (29.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$53

$-0.96 (-1.78%)

$48

12 days ago

4/10 (40%)

$2.09 (4.11%)

85

Sell

$42

$-11.96 (-22.16%)

$41

1 months 17 days ago

7/11 (63.64%)

$-5.62 (-11.80%)

195

Hold

$53

$-0.96 (-1.78%)

$66

1 months 27 days ago

2/5 (40%)

$5.94 (12.62%)

966

Hold

$52

$-1.96 (-3.63%)

$51

5 months 21 days ago

5/7 (71.43%)

$3.7 (7.66%)

50

Hold

$54

$0.04 (0.07%)

$85

8 months 3 days ago

3/8 (37.5%)

$4.74 (9.62%)

300

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BMY (Bristol-Myers Squibb Company) average time for price targets to be met?

On average it took 663.21 days on average for the stock forecasts to be realized with a an average price target met ratio 72.09

Which analyst has the current highest performing score on BMY (Bristol-Myers Squibb Company) with a proven track record?

CHRIS SCHOTT

Which analyst has the most public recommendations on BMY (Bristol-Myers Squibb Company)?

Chris Schott works at JPMORGAN and has 4 price targets and 2 ratings on BMY

Which analyst is the currently most bullish on BMY (Bristol-Myers Squibb Company)?

Andrew Baum with highest potential upside - $36.04

Which analyst is the currently most reserved on BMY (Bristol-Myers Squibb Company)?

Carter Gould with lowest potential downside - -$11.96

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?